Patent · US Active

BCL-2 inhibitors

US10377755B2 · kind B2 · utility

7Cited by
0References
13Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 26, 2018
Grant dateAug 13, 2019
Priority date—
Expiry dateJul 26, 2038

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P35/02
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The disclosure includes compounds of Formula (I)

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.